3 days ago
Immunovant (IMVT) Stock Soars Over 20% Following Breakthrough Rheumatoid Arthritis Data
Immunovant (IMVT) stock surged 22% premarket as IMVT-1402 achieved a 72.7% response rate in difficult-to-treat rheumatoid arthritis patients.
The post Immunovant (IMVT) Stock Soars Over 20% Following Breakthrough Rheumatoid Arthritis Data appeared first on Blockonomi.
Source: Blockonomi →Related News
- 14 hours ago
Hewlett Packard Enterprise (HPE) Stock Soars to Record Peak as Elliott Expands P...
- 14 hours ago
Norwegian Cruise Line (NCLH) Stock Plummets 9.5% — Company Insiders Buy Big
- 14 hours ago
Dell (DELL) Stock Rockets 16% to All-Time Peak Ahead of May 28 Earnings
- 14 hours ago
BlackBerry (BB) Stock Surges 19% to New 52-Week Peak on Bullish Outlook
- 14 hours ago
Navitas Semiconductor (NVTS) Stock Soars 20% as AI Power Shift Fuels Rally